ArticleProtein & cell2021

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction.

Wenyu Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.